EMAIL THIS PAGE TO A FRIEND

Oncotarget

A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.


PMID 26497682

Abstract

We're sorry this abstract is currently not available.